Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.

NCT01689831 is registered in ClinicalTrials.gov with JHP Pharmaceuticals LLC as lead sponsor.

NCT NCT01689831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01689831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.
Lead sponsor
JHP Pharmaceuticals LLC
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2012
Completion date
December 31, 2012
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis infection